In vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid
Author:
Funder
Japan Society for the Promotion of Science
Japan Science and Technology Agency
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference30 articles.
1. Targeting interleukin-6 signaling in clinic;Kang;Immunity,2019
2. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?;Liu;J. Autoimmun.,2020
3. Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomized SARIL-RA-MOBILITY Part A trial;Huizinga;Ann. Rheum. Dis.,2014
4. Abstract 2723: sarilumab (REGN88), a fully-human anti-IL6R antibody, inhibits tumor growth in preclinical models, as a single agent and in combination with the VEGF blocker aflibercept;Zhang;Canc. Res.,2012
5. AB0037 Evaluation of the binding kinetics and functional bioassay activity of sarilumab and tocilizumab to the human il-6 receptor (il-6r) alpha;Rafique;Ann. Rheum. Dis.,2013
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cytokine Mimetics with Various Modalities;Israel Journal of Chemistry;2024-05-14
2. SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling;Bioscience, Biotechnology, and Biochemistry;2023-11-29
3. Artificial aptamer that inhibits interleukin-23/interleukin-23 receptor interaction discovered via SELEX;Biochemical and Biophysical Research Communications;2022-07
4. Discovery of IL-5-binding unnatural cyclic peptides from multiple libraries by directed evolution;Biochemical and Biophysical Research Communications;2022-06
5. A human epidermal growth factor receptor 3/heregulin interaction inhibitor aptamer discovered using SELEX;Biochemical and Biophysical Research Communications;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3